MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Patient-Specific Outcomes of Transcutaneous Afferent Patterned Stimulation with Varying Frequencies for Essential Tremor and Parkinson’s Disease

    A. Kent, H. Kim, D. Khosla, K. Rosenbluth (Foster City, USA)

    Objective: Two studies were conducted to compare the safety, effectiveness, and comfort of fixed- and variable-frequency transcutaneous afferent patterned stimulation (TAPS) for action tremor relief…
  • 2022 International Congress

    The mGlu2 positive allosteric modulator BINA extends enhances low dose L-DOPA anti-parkinsonian action in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine the effect of positive allosteric modulation of the metabotropic glutamate type 2 (mGlu2) receptor in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset using a low…
  • 2022 International Congress

    Mapping of the International Classification of Functioning, Disability and Health categories in the Pre-Assessment Information Form for People with Parkinson’s Disease.

    F. Rogatto, E. Guelfi, G. Pereira, S. Silva (São Paulo, Brazil)

    Objective: Perform the linkage between the items of the Pre-Assessment Information Form (PAIF) of the people with Parkinson's Disease (pPD) with the categories of the…
  • 2022 International Congress

    Microglial activation facilitates alpha synuclein propagation and neurodegeneration in αSyn preformed fibrils (PFF)-injected PD mouse model

    YE. Kim, TT. Lai, F. Richter, HI. Ma (Anyang, Republic of Korea)

    Objective: To evaluate whether microglial activation aggravates synucleinopathy progression in Parkinson's disease (PD) mouse model. Background: Alpha-synuclein (αSyn) accumulation underlay the main pathological process of…
  • 2022 International Congress

    Machine learning supervised classification study for Parkinson`s disease progression through graph-based feature selection method

    V. Rama Raju, G. Ramaraju, V. Ramaraju (hyderabad, India)

    Objective: The model helps neuro physicians/ neurologists to improve the PD symptoms, or therapeutic-treatment planning-procedures. Background: Artificial intelligence-based machine learning (AI-ML) supervised classification systems have…
  • 2022 International Congress

    Beyond the subthalamic nucleus: tractography patterns of Magnetic Resonance-guided Focused Ultrasound subthalamotomy

    R. Rodriguez-Rojas, JU. Mañez-Miro, JA. Pineda-Pardo, R. Martinez-Fernandez, M. Del Alamo, JA. Obeso (Madrid, Spain)

    Objective: To identify subthalamic clusters that predict maximum improvement in bradykinesia, rigidity and tremor. To map-out the cortical fingerprint, which predict maximum efficacy. Background: Subthalamotomy…
  • 2022 International Congress

    Striatal Blood brain barrier opening in Parkinson´s disease

    C. Gasca-Salas, J. Pineda-Pardo, B. Fernández-Rodríguez, I. Obeso, F. Hernández-Fernández, C. Trompeta, R. Martínez-Fernández, M. Matarazzo, D. Mata-Marín, P. Guida, G. Foffani, G. Toltsis, I. Rachmilevitch, J. Blesa, R. Rodríguez-Rojas, M. Del-Alamo, J. Obeso (Móstoles, Spain)

    Objective: To test safety and feasibility of repeated low-intensity focused ultrasound (FUS) blood brain barrier opening (BBB) in the striatum of Parkinson’s disease (PD) patients.…
  • 2022 International Congress

    Identification and clinical characterization of GBA variants in the Luxembourg Parkinson’s Study

    S. Pachchek, Z. Landoulsi, D. Reddy Bobbili, L. Pavelka, O. Terwindt, J. Torre, A K. Hauser, C. Schulte, E. Buena-Atienza, C. Gross, N. Casadei, R. Krüger, P. May (Belvaux, Luxembourg)

    Objective: Assess the entire set of variants in the glucocerebrosidase (GBA) gene by long-read sequencing in the Luxembourg Parkinson’s study (LuxPARK) and characterize genotype-phenotype correlations…
  • 2022 International Congress

    Corticobasal syndrome and Parkinson’s disease at the beginning: usefulness of different asymmetrical patterns for early diagnosis.

    G. Donzuso, G. Sciacca, A. Luca, C. Cicero, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

    Objective: To evaluate R2 Blink Reflex Recovery Cycle (R2BRRC) and cortical thickness in drug-naïve PD patients and in CBS patients for characterizing pathophysiological mechanisms underlying…
  • 2022 International Congress

    Association of a new pathogenic variant of LRRK2 with modifying lysosomal genes in a family with Parkinson’s disease

    L. Vela-Desojo, M. Osuna-Lopez, C. Guerrero, A. Pascual, F. Palau, J. Hoenicka (Alcorcón, Spain)

    Objective: To characterize a Parkinson’s disease (PD) family with high recurrence of the disease. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder in which…
  • « Previous Page
  • 1
  • …
  • 238
  • 239
  • 240
  • 241
  • 242
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley